Imipramine pamoate

CAS : 10075-24-8

Ref. 3D-KAA07524

Informations sur le produit

• Nom: Imipramine pamoate
• Synonymes: 2-Naphthalenecarboxylic acid, 4,4′-methylenebis[3-hydroxy-, compd. with 10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine (1:2), 2-Naphthoic acid, 4,4′-methylenebis[3-hydroxy-, compd. with 5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine, 2-Naphthoic acid, 4,4′-methylenebis[3-hydroxy-, compd. with 5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine (1:2), 4,4'-methanediylbis(3-hydroxynaphthalene-2-carboxylic acid) - 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine (1:2), 5H-Dibenz[b,f]azepine, 5-[3-(dimethylamino)propyl]-10,11-dihydro-, 4,4′-methylenebis[3-hydroxy-2-naphthoate] (2:1), 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-, 4,4′-methylenebis[3-hydroxy-2-naphthalenecarboxylate] (2:1), Imipramine Pamoate
• CAS: 10075-24-8

Description

Imipramine pamoate is a kinase inhibitor that has been shown to induce apoptosis in human cancer cells. It is an analog of amphetamine and has potent anticancer activity. Imipramine pamoate works by inhibiting the activity of several kinases, including protein kinase C and mitogen-activated protein kinase (MAPK), which are involved in cell growth and survival. This drug has been found to be effective against a variety of tumors, including breast, lung, and colon cancers. Imipramine pamoate is excreted in urine and can be used as a biomarker for cancer diagnosis or monitoring.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 949.2 g/mol
• Formule: C₆₁H₆₄N₄O₆
• Degré de pureté: Min. 95%